TickerFacts.

Neuraxis, Inc (NRXS): Revenue

Annual figures by period end, from SEC filings.

$3.57M
Year ended 2025-12-31
$5.32M
Trailing 12 months to 2026-06-30
+10.0%
3-year compound annual growth
2022-12-31: $2.68M2023-12-31: $2.46M2024-12-31: $2.69M2025-12-31: $3.57M$3.57M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$3.57M+32.9%2026-03-19, From 2025-01-01
2024-12-31$2.69M+9.2%2026-03-19, From 2024-01-01
2023-12-31$2.46M-8.4%2025-03-20, From 2023-01-01
2022-12-31$2.68Mn/a2024-04-16, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Neuraxis, Inc (NRXS)2025-12-31$3.57M+32.9%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$3.35M+4.7%
Hongchang International Co., Ltd (HCIL)2024-12-31$2.87M+7.1%
Nuwellis, Inc. (NUWE)2025-12-31$8.27M-5.4%
Escalon Medical Corp (ESMC)2025-06-30$12.05M+0.5%
CapsoVision, Inc (CV)2025-12-31$13.55M+15.3%
Hyperfine, Inc. (HYPR)2025-12-31$13.56M+5.2%
Guided Therapeutics Inc (GTHP)2025-12-31$767.0Kn/m
QT Imaging Holdings, Inc. (QTI)2025-12-31$18.93M+287.9%

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗